Cambridge Investment Research Advisors
DVAX

Cambridge Investment Research Advisors’s Dynavax Technologies DVAX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,044
Closed -$312K – 3662
2025
Q1 		$312K Buy
+24,044
New +$318K ﹤0.01% 2830
2024
Q4 		– Sell
-11,290
Closed -$126K – 3503
2024
Q3 		$126K Hold
11,290
– – ﹤0.01% 3231
2024
Q2 		$127K Sell
11,290
-1,075
-9% -$12.5K ﹤0.01% 3123
2024
Q1 		$153K Hold
12,365
– – ﹤0.01% 3087
2023
Q4 		$173K Buy
+12,365
New +$172K ﹤0.01% 2941
2023
Q2 		– Sell
-11,125
Closed -$109K – 3204
2023
Q1 		$109K Sell
11,125
-2,000
-15% -$21.3K ﹤0.01% 2957
2022
Q4 		$140K Hold
13,125
– – ﹤0.01% 2849
2022
Q3 		$137K Sell
13,125
-1,035
-7% -$13.5K ﹤0.01% 2801
2022
Q2 		$178K Buy
14,160
+350
+3% +$3.72K ﹤0.01% 2750
2022
Q1 		$150K Sell
13,810
-1,600
-10% -$19.4K ﹤0.01% 2942
2021
Q4 		$217K Sell
15,410
-1,409
-8% -$23.2K ﹤0.01% 2813
2021
Q3 		$323K Sell
16,819
-6,184
-27% -$82.1K ﹤0.01% 2399
2021
Q2 		$227K Sell
23,003
-17,000
-42% -$155K ﹤0.01% 2710
2021
Q1 		$393K Sell
40,003
-10,500
-21% -$86.6K ﹤0.01% 2075
2020
Q4 		$225K Sell
50,503
-4,947
-9% -$22.4K ﹤0.01% 2385
2020
Q3 		$240K Buy
55,450
+9,000
+19% +$64.2K ﹤0.01% 2105
2020
Q2 		$412K Buy
46,450
+11,800
+34% +$59.6K ﹤0.01% 1670
2020
Q1 		$122K Sell
34,650
-3,025
-8% -$14K ﹤0.01% 2073
2019
Q4 		$216K Sell
37,675
-1,200
-3% -$6.42K ﹤0.01% 2153
2019
Q3 		$139K Sell
38,875
-1,000
-3% -$3.88K ﹤0.01% 2190
2019
Q2 		$159K Sell
39,875
-3,000
-7% -$17.4K ﹤0.01% 2043
2019
Q1 		$313K Sell
42,875
-310
-0.7% -$3.03K ﹤0.01% 1778
2018
Q4 		$395K Sell
43,185
-1,500
-3% -$16.6K ﹤0.01% 1457
2018
Q3 		$554K Buy
+44,685
New +$605K 0.01% 1382

Other funds holding DVAX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Cambridge Investment Research Advisors's DVAX Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 24,044 shares — an estimated $312K sold.

Cambridge Investment Research Advisors first reported a position in DVAX in Q3 2018 and held it in 24 quarters. The position peaked at $554K in Q3 2018. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Cambridge Investment Research Advisors reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 24,044 Dynavax Technologies shares in Q2 2025, an estimated $312K.
  • Cambridge Investment Research Advisors first reported a position in Dynavax Technologies in Q3 2018 and held it in 24 quarters.
  • Cambridge Investment Research Advisors's Dynavax Technologies position peaked at $554K in Q3 2018.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.